isoflurane has been researched along with am-356 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bedoya, M; Decher, N; González, W; Kiper, AK; Ramírez, D; Rinné, S | 1 |
| Anetseder, M; Berkowitz, C; Eberhart, L; Eckenhoff, R; Hanley, PJ; Preisig-Müller, R; Putzke, C; Rinné, S; Schlichthörl, G; Vassiliou, T; Wulf, H | 1 |
1 review(s) available for isoflurane and am-356
| Article | Year |
|---|---|
TASK Channels Pharmacology: New Challenges in Drug Design.
Topics: Animals; Drug Design; Drug Discovery; Humans; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Tandem Pore Domain | 2019 |
1 other study(ies) available for isoflurane and am-356
| Article | Year |
|---|---|
Differential effects of volatile and intravenous anesthetics on the activity of human TASK-1.
Topics: Anesthetics, Inhalation; Anesthetics, Intravenous; Animals; Arachidonic Acids; Cells, Cultured; Dose-Response Relationship, Drug; Etomidate; Halothane; Humans; Hydrogen-Ion Concentration; Isoflurane; Membrane Potentials; Methyl Ethers; Myocytes, Cardiac; Nerve Tissue Proteins; Oocytes; Patch-Clamp Techniques; Potassium; Potassium Channel Blockers; Potassium Channels, Tandem Pore Domain; Propofol; Rats; RNA, Complementary; Sevoflurane; Xenopus laevis | 2007 |